PEDIATRICS Vol. 37 No. 1 January 1966, pp. 138-139
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EIDELMAN, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by EIDELMAN, A.

To the Executive Director of the Academy of Pediatrics:

ARTHUR EIDELMAN M.D.1

1 Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut

A recent advertisement in Pediatrics (June 1965), raises a question as to the efficacy of the process for reviewing advertising copy.

The advertisement in point is from Merck Sharpe and Dome Co. which proclaims that the hospitalization of an infant with croup (viral?, H. influenza?, spasmodic?), can be averted by the timely injection of Decadron (dexamethasone). Nowhere in the advertisement are any appropriate references cited to support this still controversial mode of therapy.

in reviewing the literature, this reader is struck by the lack of any well controlled study indicating value to steriod therapy in the management of the hospitalized croup patient, let alone in home treatment.




This article has been cited by other articles:


Home page
 PediatricsHome page
L. M. Gartner and R. H. Moser
The "Fourth Part" of Pediatrics: 50 Years of Display Advertising
Pediatrics, July 1, 1998; 102(1): 177 - 185.
[Full Text]